ELI LILLY & Co

Report Publication Announcement • May 11, 2018

Lilly to Participate in UBS Global Healthcare Conference

INDIANAPOLIS, May 11,2018 /PRNewswire/ --

Eli Lilly and Company (NYSE:LLY) will attend the UBS Global Healthcare Conference on Tuesday, May 22, 2018. Enrique Conterno, senior vice president of Lilly and president of Lilly Diabetes and Lilly USA, will participate in a fireside chat at 10:30 a.m., Eastern Time.

(Logo: https://mma.prnewswire.com/media/458388/Eli_Lilly_Logo.jpg )

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at http://investor.lilly.com/events.cfm . A replay of the presentation will be available on this same website for approximately 90 days.

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY 

Refer to: Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media)

Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors)

This is a disclosure announcement from PR Newswire.